NuCana plc

Contributing Author

Recent Articles by NuCana plc

Jan-06	NuCana Appoints Theresa Bruce as Chief Operating Officer NCNA GlobeNewswire
Dec-10	NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma NCNA GlobeNewswire
Nov-13	NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update NCNA GlobeNewswire
Nov-05	NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China NCNA GlobeNewswire
Oct-18	NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025 NCNA GlobeNewswire
Oct-14	NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy NCNA GlobeNewswire
Sep-05	NuCana Compliant with All Nasdaq Continued Listing Criteria NCNA GlobeNewswire
Sep-03	NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025 NCNA GlobeNewswire
Aug-20	NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update NCNA GlobeNewswire
Aug-01	NuCana Announces ADS Ratio Change NCNA GlobeNewswire
Jul-21	NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution NCNA GlobeNewswire
Jul-11	NuCana Announces Plan to Implement ADS Ratio Change NCNA GlobeNewswire
Jun-02	NuCana Reports First Quarter 2025 Financial Results and Provides Business Update NCNA GlobeNewswire
May-06	NuCana Prices $7 Million Registered Direct Offering NCNA GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.